Literature DB >> 11846399

Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells.

Marc-André Raymond1, Normand Vigneault, Valerie Luyckx, Marie-Josée Hébert.   

Abstract

The mechanisms of cytoprotection conferred by stress preconditioning remain largely uncharacterized in endothelial cells (EC). We report that stress preconditioning of EC with serum starvation induces the release of soluble mediator(s) that confer resistance to apoptosis, increase proliferation, and enhance angiogenesis in a second set of "non-preconditioned" EC. Preconditioning was found to target specifically the mitochondrial control of apoptosis in EC with increased protein levels of Bcl-2, decreased protein levels of Bax, and decreased cytosolic release of cytochrome c. Regulators of apoptosis acting upstream and downstream of the mitochondria such as p53, cIAP-1, cIAP-2, and XIAP were not altered. Mediators classically associated with preconditioning in other cell types such as adenosine, opioids, and nitric oxide are not implicated in this cytoprotective loop. Blockade of protein kinase C-dependent signaling inhibited cytoprotection of EC. Further characterization of this paracrine pathway should provide insights into the molecular regulation of preconditioning in endothelial cells. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846399     DOI: 10.1006/bbrc.2002.6449

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling.

Authors:  Shyh-Jong Wu; Mathilde Soulez; Ya-Hui Yang; Chih-Sheng Chu; Shih-Chuan Shih; Marie-Josée Hébert; Mei-Chuan Kuo; Ya-Ju Hsieh
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

2.  Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.

Authors:  Elena Raschi; Daniela Privitera; Caterina Bodio; Paola Adele Lonati; Maria Orietta Borghi; Francesca Ingegnoli; Pier Luigi Meroni; Cecilia Beatrice Chighizola
Journal:  Arthritis Res Ther       Date:  2020-11-09       Impact factor: 5.156

3.  RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.

Authors:  Sam Cross-Knorr; Shaolei Lu; Kimberly Perez; Sara Guevara; Kate Brilliant; Claudio Pisano; Peter J Quesenberry; Murray B Resnick; Devasis Chatterjee
Journal:  BMC Cancer       Date:  2013-10-08       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.